ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q2 2021. The put-call ratio across all filers is 1.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $541,917 | -13.6% | 20,071 | -1.7% | 0.00% | 0.0% |
| Q2 2023 | $627,037 | -18.6% | 20,418 | -4.5% | 0.00% | 0.0% |
| Q1 2023 | $770,393 | +12.3% | 21,382 | +25.3% | 0.00% | 0.0% |
| Q3 2022 | $686,000 | -14.8% | 17,065 | -10.9% | 0.00% | 0.0% |
| Q2 2022 | $805,000 | +128.0% | 19,144 | +116.2% | 0.00% | – |
| Q4 2021 | $353,000 | -65.8% | 8,856 | -69.0% | 0.00% | -100.0% |
| Q3 2021 | $1,031,000 | +1.0% | 28,534 | +14.6% | 0.00% | 0.0% |
| Q2 2021 | $1,021,000 | -6.0% | 24,900 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $1,086,000 | -12.8% | 24,900 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $1,246,000 | – | 24,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |